| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Emergent Biosolutions Inc. (EBS) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. EBS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 374.1K | $3.12M | - | |
| CEO | 305.4K | $2.55M | - | |
| VP | 202.2K | $1.69M | - | |
| VP | 185.6K | $1.55M | - | |
| VP | 162.1K | $1.35M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2016 | Havey Adam | EVP, Biodefense Divison | Sell | 4,359 | $33.96 | $148,031.64 | -5.4% | |
| Mar 14, 2016 | Hauer Jerome M | Director | Sell | 2,350 | $33.88 | $79,618.00 | -14.3% | |
| Mar 11, 2016 | Havey Adam | EVP, Biodefense Divison | Sale+OE | 11,112 | $33.84 | $376,030.08 | -11.1% | |
| Mar 11, 2016 | Sullivan Louis W62 | Director | Sale+OE | 14,879 | $34.03 | $506,332.37 | -34.3% | |
| Mar 10, 2016 | Sullivan Louis W62 | Director | Sale+OE | 14,820 | $35.34 | $523,738.80 | -34.2% | |
| Mar 7, 2016 | White Marvin L | Director | Sale+OE | 33,134 | $35.42 | $1,173,606.28 | -17.9% | |
| Jan 4, 2016 | Bailey Sue | Director | Sale+OE | 11,520 | $38.79 | $446,889.60 | -11.9% | |
| Dec 30, 2015 | Richard Ronald | Director | Sale+OE | 21,600 | $40.00 | $864,000.00 | -61.1% | |
| Dec 24, 2015 | Abdun-Nabi Daniel | President &CEO | Sale+OE | 63,209 | $39.06 | $2,468,632.81 | -14.6% | |
| Nov 19, 2015 | El-Hibri Fuad | Chairman | Sale+OE | 17,871 | $37.50 | $670,162.50 | -1.0% |